Sun Pharma’s U.S. Arm Agrees To Settle Multi-Million Dollar Drug Price-Fixing Charges

Sun Pharmaceutical Industries Ltd.’s U.S. subsidiary has agreed to pay more than $400 million to settle charges that it conspired to fix prices of generic drugs, in a long-running investigation by ...